PT MITSUBISHI TANABE PHARMA INDONES

Company Profile:

PT Mitsubishi Tanabe Pharma Indonesia is primarily a **factory** (manufacturing facility) for pharmaceutical products. It also handles the sales and distribution of these products within Indonesia.

Company Introduction:

PT Mitsubishi Tanabe Pharma Indonesia is a subsidiary of Mitsubishi Tanabe Pharma Corporation, a prominent Japanese pharmaceutical company. Its core business in Indonesia involves the manufacturing, marketing, and distribution of various pharmaceutical products. The company is dedicated to providing high-quality medicines and healthcare solutions to the Indonesian market, adhering to the stringent research, development, and quality control standards established by its parent company. Its operations combine local production capabilities with a comprehensive commercial network for product dissemination.

Enterprise Products

PT MITSUBISHI TANABE PHARMA INDONESIA manufactures or sells the following products:

Tenelia (Teneligliptin)

Radicut (Edaravone)

Talion (Bepotastine Besilate)

Remicade (Infliximab)

Business Registration Information:

Manager:

Mr. Junichi Shimizu (President Director)

Phone:

+62 21 5790 3000

E-mail:

Not publicly listed on their official website for general inquiries.

Official Website:

mitsubishi-tanabe.co.id

Address:

Wisma GKBI, 23rd Floor, Jl. Jend. Sudirman No.28, RT.13/RW.1, Bendungan Hilir, Tanah Abang, Central Jakarta City, Special Capital Region of Jakarta 10210, Indonesia

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.